DR. REDDY'S LABORATORIES LIMITED Dr. Reddy's Laboratories Limited Share Price NSE India S.E.
Equities
DRREDDY
INE089A01023
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,812 INR | +0.21% |
|
-1.64% | +0.24% |
| 05-16 | Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading | MT |
| 05-15 | Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading | MT |
| Sales 2024 | 280B 3.36B 265B | Sales 2025 * | 300B 3.61B 284B | Capitalization | 966B 11.6B 913B |
|---|---|---|---|---|---|
| Net income 2024 | 55.78B 670M 52.75B | Net income 2025 * | 55.26B 664M 52.26B | EV / Sales 2024 | 3.43 x |
| Net cash position 2024 | 64.59B 776M 61.08B | Net cash position 2025 * | 90.85B 1.09B 85.92B | EV / Sales 2025 * | 2.91 x |
| P/E ratio 2024 |
18.4
x | P/E ratio 2025 * |
17.3
x | Employees | 25,863 |
| Yield 2024 |
0.65% | Yield 2025 * |
0.78% | Free-Float | 70.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Dr. Reddy's Laboratories Limited
More recommendations
More press releases
More news
| 1 day | +0.21% | ||
| 1 week | -1.64% | ||
| Current month | -6.33% | ||
| 1 month | -2.44% | ||
| 3 months | -9.44% | ||
| 6 months | +3.70% | ||
| Current year | +0.24% |
1 week
5 709.00
5 966.95
1 month
5 709.006 419.90
Current year
5 520.656 505.90
1 year
4 384.056 505.90
3 years
3 654.006 505.90
5 years
2 351.206 505.90
10 years
1 872.956 505.90
| Managers | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 01/04/18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 01/11/20 |
| Chairman | 56 | 17/01/93 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 07/04/86 |
| Chairman | 56 | 17/01/93 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 04/06/07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/05/24 | 5,812 | +0.21% | 22 645 |
| 17/05/24 | 5,800 | -0.87% | 601,339 |
| 16/05/24 | 5,850 | -0.42% | 732,097 |
| 15/05/24 | 5,875 | +0.11% | 291,681 |
| 14/05/24 | 5,869 | -0.67% | 237,330 |
Delayed Quote NSE India S.E., May 18, 2024 at 08:19 am
More quotes
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
20/05/2024
- Investor Meeting - Macquarie
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
5,799
INR
Average target price
6,101
INR
Spread / Average Target
+5.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- DRREDDY Stock
- DRREDDY Stock
